Stocktoria
PULSE BIOSCIENCES, INC. PLSE
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2016-05-18
PULSE BIOSCIENCES, INC. statistics & valuation
Market cap$2.0B
P / B24.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -21982.6% | — | — | -8293.9% | -4443.9% |
| Net margin | -20794.6% | — | — | -8357.9% | -4489.4% |
| FCF margin | -15553.4% | — | — | -6773.4% | -3845.8% |
| Return on assets | -77.0% | -40.5% | -71.4% | -75.1% | -107.6% |
| Return on equity | -90.2% | -46.7% | -95.2% | 2602.5% | -143.5% |
| Current ratio | 10.53 | 11.88 | 6.76 | 10.39 | 6.76 |
| Revenue growth | — | — | -100.0% | -50.6% | — |
Source: SEC EDGAR filings · CIK 0001625101 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.